Technology Transfer, CDMO/CRO & External Manufacturing Oversight

Outsourcing the work does not outsource the CMC accountability.

XGene helps sponsors translate technical intent into partner selection, transfer packages, governance, change control, performance evidence and escalation mechanisms that keep external execution aligned with regulatory commitments.

When this service is the right fit

• A partner was selected commercially before technical fit and governance risks were fully assessed.
• Transfer packages describe methods and processes but do not transfer the rationale behind critical controls.
• Sponsor and CDMO responsibilities are unclear at deviations, changes, investigations or regulatory milestones.
• Data arrives too late or in formats that make CMC review and submission reuse difficult.
• Repeated partner delays are treated as project-management issues when the real causes are technical or governance-related.
• A transfer or scale-up needs independent readiness review before execution.

What XGene does

• Define technical, regulatory, quality and data requirements before partner selection or transfer.
• Assess partner capabilities, gaps, governance model and evidence maturity.
• Build or review transfer plans, acceptance criteria, comparability needs and documentation requirements.
• Establish sponsor/partner RACI, meeting cadence, escalation and change/deviation interfaces.
• Review execution evidence, batch history, analytical performance and transfer closure.
• Connect external-manufacturing outputs to the sponsor’s CMC dossier and lifecycle commitments.

What the engagement produces

• Partner/transfer readiness assessment
• Technical due-diligence and risk register
• Transfer package and acceptance-criteria review
• Sponsor/CDMO governance and escalation model
• Data/documentation deliverable matrix
• Transfer closure / ongoing oversight dashboard structure

Productized starting point — Technology Transfer / External Partner Readiness Review

The Technology Transfer / External Partner Readiness Review is the recommended first engagement when the organization needs an independent, evidence-based view before committing to a larger remediation, authoring, transformation or execution program. It is designed to identify the decision-critical gaps, clarify scope and produce a prioritized path forward without forcing the client into an oversized engagement at the outset.

How XGene works

1. Define what the partner must deliver and what the sponsor must remain able to defend.

2. Map technical, data and quality dependencies.

3. Diagnose partner/transfer risks before they become execution failures.

4. Build the transfer and governance architecture.

5. Stress-test deviations, changes, delays and regulatory data handoffs.

Senior practitioners aligned to this work

• a senior XGene biologics CMC / MS&T practitioner
• a senior XGene process-chemistry
• CDMO and technology-transfer practitioner
• a senior XGene manufacturing
• analytical and technology-transfer practitioner
• Khaled Aamer, PhD

Experience brought to XGene

The following examples demonstrate relevant practitioner experience. They are not presented as XGene-delivered client outcomes unless explicitly stated otherwise.

• Transfer of four late-stage/commercial molecules and extensive biologics transfer/validation work in prior-role experience (a senior XGene biologics CMC / MS&T practitioner).
• Prior-role and consulting experience includes CRO/CDMO RFP development, vendor selection, technical audits, project/program management and API scale-up (a senior XGene process-chemistry, CDMO and technology-transfer practitioner).
• Prior-role experience includes product launches, analytical/QC leadership and manufacturing/technology-transfer support (a senior XGene manufacturing, analytical and technology-transfer practitioner).
• Global CMO oversight across the US, EU, Asia and Japan for complex CMC programs in prior-role experience (Khaled Aamer).

Engagement boundary

This service complements commercial sourcing and legal contracting; it focuses on the technical, CMC, quality and governance conditions required for a defensible outsourced program.